Register
Login:
Share:
Email Facebook Twitter

Early Stage Investment Opportunities: SyndicateRoom, investing from idea to IPO. Watch here

Share Views Episode 9 - Early Stage Investment Opportunities


Sareum Share Chat (SAR)



Share Price: 0.655Bid: 0.63Ask: 0.68Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.05Spread as %: 7.94%Open: 0.635High: 0.655Low: 0.615Yesterday’s Close: 0.655


Share Discussion for Sareum


Thread View

Please login or register to post a message on Share Chat.

Posts per page:


diggit1gold
Posts: 703
Off Topic
Opinion:No Opinion
Price:0.655
Good one
Sat 22:12
DEL and apologies for putting you on the spot!. I get a wee bit twitchy/cranky when peeps are negative coz i worked all my days in the research side and it,s very frustrating to keep passing time without perceived progress. Even to get to the Phase 1 human trials stage SAR are now at, it,s probably taken at least 10 years. The road is long. :o).
 
Obelix
Posts: 9,762
Off Topic
Opinion:No Opinion
Price:0.655
View Thread (2)
RE: Obelix
Sat 01:58
Yes Mate, I'm okay thank you for asking.
Have been busy at Uni, family issues and work, I hope SAR release good news soon Mate, I believe those Sells this week was some PI's that was little bit fed up with SAR - Public Relation.
Good luck to you & others here, let's see how SAR will be next week.
Have a nice weekend Mate, take care.
Obelix
minden
Posts: 1,124
Off Topic
Opinion:No Opinion
Price:0.655
Obelix
Fri 22:14
Hope ur ok. Where are you
Hopkirk
Posts: 1,560
Off Topic
Opinion:No Opinion
Price:0.655
RE: Hopkirk /Thoth etc?
Fri 19:55
JonTangle. Not 100% sure but it looks like It has something to do with assessing the impact of cct 244747 has on the heart / heart disease and if this is influenced by genetics or environmental factors.

I think
JonTangle
Posts: 148
Off Topic
Opinion:No Opinion
Price:0.655
Another...
Fri 19:39
CCT244747 gets mentioned about 3/4 of the way down under 'ATR pathway implicated in APOBEC3 regulation'.

https://genomebiology.biomedcentral.com/articles/10.1186/s13059-016-1042-9

Guts are rumbling again. I'm off for

APOOOO
JonTangle
Posts: 148
Off Topic
Opinion:No Opinion
Price:0.655
Hopkirk /Thoth etc?
Fri 19:19
http://www.careersfromscience.org/index.php/2016/09/23/objective-to-determine-if-biomarkers-of-oxidized-lipoproteins-are-genetically-determined/

I'll be goosed if it makes any sense to me??? I swear it's incomplete?

Anyway, had a big dinner, so I'm going for

APOOOOOOO
DELSTER
Posts: 388
Premium Chat Member
Observation
Opinion:No Opinion
Price:0.655
RE: RE:RE:RE: I don't know
Fri 19:15
Not at all,I'm already heavily invested here and would love to see the trails being positive,and a 5p SP,as were all going to need treatment at some stage of our lives.Im just saying if it did fall to the 30s I shall load up even more.
Num4
Posts: 975
Off Topic
Opinion:No Opinion
Price:0.655
Parker on another board
Fri 18:14
minden
Posts: 1,124
Off Topic
Opinion:Strong Buy
Price:0.655
Said
Fri 16:45
it would turn blue at close . Hoping for a good next week
minden
Posts: 1,124
Off Topic
Opinion:Strong Buy
Price:0.625
Today
Fri 16:32
2.5 more buys than sells . This seems to be a daily pattern . Surely a positive sign for next week




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.